Loading...

Pamela Sue Becker

Title(s)Clinical Professor, Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Glucocerebrosidase Gene Transfer to the Nervous System
    NIH/NICHD R21HD044095Aug 7, 2002 - Jun 30, 2005
    Role: Co-Principal Investigator
    RETROVIRAL TRANSFER OF ANKYRIN FOR SPHEROCYTOSIS
    NIH/NHLBI R01HL063184Jul 1, 1999 - May 31, 2004
    Role: Principal Investigator
    HEMATOPOIETIC STEM CELL GROWTH AND ENGRAFTMENT
    NIH/NHLBI P01HL056920Sep 1, 1996 - Aug 31, 2002
    Role: Principal Investigator
    CYTOSKELETAL REGULATION BY EXTRACELLULAR MATRIX ADHESION
    NIH/NHLBI K08HL002656Aug 1, 1991 - Jul 31, 1996
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: long term follow-up from a Phase 1b study. Am J Hematol. 2020 Oct 29. Pollyea DA, Pratz K, Letai A, Jonas BA, Wei AH, Pullarkat V, Konopleva M, Thirman MJ, Arellano M, Becker PS, Chyla B, Hong WJ, Jiang Q, Potluri J, DiNardo CD. PMID: 33119898.
      View in: PubMed   Mentions:    Fields:    
    2. Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm. J Clin Oncol. 2020 Oct 08; JCO2001392. Palmieri R, Othus M, Halpern AB, Percival MM, Godwin CD, Becker PS, Walter RB. PMID: 33030979.
      View in: PubMed   Mentions:    Fields:    
    3. A phase 1b study of onvansertib, a novel oral PLK1 inhibitor, in combination therapy for patients with relapsed or refractory acute myeloid leukemia. Clin Cancer Res. 2020 Sep 30. Zeidan AM, Ridinger M, Lin TL, Becker PS, Schiller G, Patel PA, Spira AI, Tsai ML, Samuëlsz E, Silberman SL, Erlander M, Wang ES. PMID: 32998961.
      View in: PubMed   Mentions:    Fields:    
    4. Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic. J Natl Compr Canc Netw. 2020 Sep 01; 1-4. Griffiths EA, Alwan LM, Bachiashvili K, Brown A, Cool R, Curtin P, Geyer MB, Gojo I, Kallam A, Kidwai WZ, Kloth DD, Kraut EH, Lyman GH, Mukherjee S, Perez LE, Rosovsky RP, Roy V, Rugo HS, Vasu S, Wadleigh M, Westervelt P, Becker PS. PMID: 32871558.
      View in: PubMed   Mentions:    Fields:    
    5. Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML. Cancer Med. 2020 Jul 24. Sorror ML, Agarwal S, Othus M, Lynch Y, Nyland JE, Percival ME, Becker PS, Appelbaum FR, Estey EH. PMID: 32706528.
      View in: PubMed   Mentions: 1     Fields:    
    6. 90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma. Bone Marrow Transplant. 2020 Jul 24. Tuazon SA, Sandmaier BM, Gooley TA, Fisher DR, Holmberg LA, Becker PS, Lundberg SJ, Orozco JJ, Gopal AK, Till BG, Coffey DG, Nartea ME, Matesan MC, Pagel JM, Rajendran JG, Press OW, Bensinger WI, Green DJ. PMID: 32710011.
      View in: PubMed   Mentions:    Fields:    
    7. Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility. Haematologica. 2020 Jul 09. Percival MM, Othus M, Mirahsani S, Gardner KM, Shaw C, Halpern AB, Becker PS, Hendrie PC, Sorror ML, Walter RB, Estey EH. PMID: 32646891.
      View in: PubMed   Mentions:    Fields:    
    8. Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney. Leukemia. 2020 Oct; 34(10):2776-2779. Wong RL, Ketcham M, Irwin T, Akilesh S, Zhang TY, Reyes JD, Edlefsen K, Jalikis F, Becker PS. PMID: 32523036.
      View in: PubMed   Mentions:    Fields:    
    9. Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome. Blood Adv. 2020 05 12; 4(9):2032-2043. Lee JH, Faderl S, Pagel JM, Jung CW, Yoon SS, Pardanani AD, Becker PS, Lee H, Choi J, Lee K, Kim M, Cortes JE. PMID: 32396615.
      View in: PubMed   Mentions:    Fields:    
    10. KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2020 Sep; 20(9):602-609. Cowan AJ, Green DJ, Karami M, Becker PS, Tuazon S, Coffey DG, Hyun TS, Libby EN, Gopal AK, Holmberg LA. PMID: 32457024.
      View in: PubMed   Mentions:    Fields:    
    11. Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood Adv. 2020 02 25; 4(4):611-616. Mabrey FL, Gardner KM, Shannon Dorcy K, Perdue A, Smith HA, Davis AM, Hammer C, Rizzuto D, Jones S, Quach K, Scott BL, Hendrie PC, Percival MM, Walter RB, Appelbaum FR, Estey EH, Becker PS. PMID: 32074276.
      View in: PubMed   Mentions: 1     Fields:    
    12. Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm. Leuk Lymphoma. 2020 07; 61(7):1728-1731. Palmieri R, Buckley SA, Othus M, Halpern AB, Percival MM, Scott BL, Hendrie PC, Becker PS, Oehler VG, Estey EH, Walter RB. PMID: 32077361.
      View in: PubMed   Mentions:    Fields:    
    13. NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020. J Natl Compr Canc Netw. 2020 01; 18(1):12-22. Becker PS, Griffiths EA, Alwan LM, Bachiashvili K, Brown A, Cool R, Curtin P, Dinner S, Gojo I, Hicks A, Kallam A, Kidwai WZ, Kloth DD, Kraut EH, Landsburg D, Lyman GH, Miller R, Mukherjee S, Patel S, Perez LE, Poust A, Rampal R, Rosovsky R, Roy V, Rugo HS, Shayani S, Vasu S, Wadleigh M, Westbrook K, Westervelt P, Burns J, Keller J, Pluchino LA. PMID: 31910384.
      View in: PubMed   Mentions: 5     Fields:    
    14. Need for routine examination of left ventricular ejection fraction in patients with AML. Leukemia. 2020 04; 34(4):1169-1171. Khan HM, Gardner KM, Shaw C, Halpern AB, Huebner EM, Percival MM, Mirahsani S, Sorror ML, Becker PS, Walter RB, Estey EH. PMID: 31719680.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma. Clin Cancer Res. 2020 01 15; 26(2):344-353. Ghobrial IM, Liu CJ, Redd RA, Perez RP, Baz R, Zavidij O, Sklavenitis-Pistofidis R, Richardson PG, Anderson KC, Laubach J, Henrick P, Savell A, Reyes K, Hornburg K, Chuma S, Sabbatini P, Robbins MD, Becker PS. PMID: 31672767.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    16. Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm. Leukemia. 2020 02; 34(2):635-639. Halpern AB, Howard NP, Othus M, Hendrie PC, Baclig NV, Buckley SA, Percival MM, Becker PS, Scott BL, Oehler VG, Gernsheimer TB, Keel SB, Orozco JJ, Cassaday RD, Shustov AR, Hartley GA, Welch VL, Estey EH, Walter RB. PMID: 31586148.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma. Acta Haematol. 2020; 143(2):146-154. Holmberg LA, Green D, Libby E, Becker PS. PMID: 31434076.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Independent Associations Between Glomerular Filtration Rate and Serum Bilirubin Level and Early Mortality in Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2019 12; 19(12):e633-e635. Bezerra ED, Othus M, Shawn C, Percival ME, Gardner K, Walter RB, Becker PS, Hendrie PC, Estey EH. PMID: 31648955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia. Blood Adv. 2019 07 09; 3(13):1939-1949. Erba HP, Becker PS, Shami PJ, Grunwald MR, Flesher DL, Zhu M, Rasmussen E, Henary HA, Anderson AA, Wang ES. PMID: 31253596.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    20. Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes. Blood. 2019 07 11; 134(2):186-198. Hsu J, Reilly A, Hayes BJ, Clough CA, Konnick EQ, Torok-Storb B, Gulsuner S, Wu D, Becker PS, Keel SB, Abkowitz JL, Doulatov S. PMID: 31010849.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    21. Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms. Haematologica. 2019 04; 104(4):e143-e146. Halpern AB, Othus M, Huebner EM, Scott BL, Hendrie PC, Percival MM, Becker PS, Smith HA, Oehler VG, Orozco JJ, Cassaday RD, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Estey EH, Walter RB. PMID: 30409798.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    22. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019 01 03; 133(1):7-17. DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH, Kantarjian HM, Xu T, Hong WJ, Chyla B, Potluri J, Pollyea DA, Letai A. PMID: 30361262.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    23. A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leuk Lymphoma. 2019 04; 60(4):1023-1029. Buckley SA, Percival ME, Othus M, Halpern AB, Huebner EM, Becker PS, Shaw C, Shadman M, Walter RB, Estey EH. PMID: 30277112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. Haematologica. 2019 02; 104(2):380-391. Maffini E, Storer BE, Sandmaier BM, Bruno B, Sahebi F, Shizuru JA, Chauncey TR, Hari P, Lange T, Pulsipher MA, McSweeney PA, Holmberg L, Becker PS, Green DJ, Mielcarek M, Maloney DG, Storb R. PMID: 30262560.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A. Haematologica. 2018 11; 103(11):1806-1814. Adair JE, Chandrasekaran D, Sghia-Hughes G, Haworth KG, Woolfrey AE, Burroughs LM, Choi GY, Becker PS, Kiem HP. PMID: 29976742.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    26. Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms. Leukemia. 2018 11; 32(11):2352-2362. Halpern AB, Othus M, Huebner EM, Scott BL, Becker PS, Percival MM, Hendrie PC, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Appelbaum FR, Erba HP, Estey EH, Walter RB. PMID: 29720734.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    27. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy. Biol Blood Marrow Transplant. 2018 07; 24(7):1386-1391. Cowan AJ, Stevenson PA, Libby EN, Becker PS, Coffey DG, Green DJ, Hyun TS, Fromm JR, Gopal AK, Holmberg LA. PMID: 29481870.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    28. Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD. Am J Hematol. 2018 08; 93(4):546-552. Cassaday RD, Stevenson PA, Wood BL, Becker PS, Hendrie PC, Sandmaier BM, Radich JL, Shustov AR. PMID: 29318644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun. 2018 01 03; 9(1):42. Lee SI, Celik S, Logsdon BA, Lundberg SM, Martins TJ, Oehler VG, Estey EH, Miller CP, Chien S, Dai J, Saxena A, Blau CA, Becker PS. PMID: 29298978.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    30. Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm. Haematologica. 2018 03; 103(3):e106-e109. Walter RB, Othus M, Orlowski KF, McDaniel EN, Scott BL, Becker PS, Percival MM, Hendrie PC, Medeiros BC, Chiarella MT, Louie AC, Estey EH. PMID: 29242304.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    31. Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 12; 15(12):1520-1541. Crawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P, Dinner S, Fynan T, Gojo I, Griffiths EA, Hough S, Kloth DD, Kuter DJ, Lyman GH, Mably M, Mukherjee S, Patel S, Perez LE, Poust A, Rampal R, Roy V, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Talbott M, Vadhan-Raj S, Vasu S, Wadleigh M, Westervelt P, Burns JL, Pluchino L. PMID: 29223990.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    32. Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality. JAMA Oncol. 2017 12 01; 3(12):1675-1682. Sorror ML, Storer BE, Fathi AT, Gerds AT, Medeiros BC, Shami P, Brunner AM, Sekeres MA, Mukherjee S, Peña E, Elsawy M, Wardyn S, Whitten J, Moore R, Becker PS, McCune JS, Appelbaum FR, Estey EH. PMID: 28880971.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Controversies Regarding Use of Myeloid Growth Factors in Leukemia. J Natl Compr Canc Netw. 2017 12; 15(12):1551-1557. Poston JN, Becker PS. PMID: 29223992.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma. Blood Adv. 2017 Nov 14; 1(24):2247-2256. Green DJ, Maloney DG, Storer BE, Sandmaier BM, Holmberg LA, Becker PS, Fang M, Martin PJ, Georges GE, Bouvier ME, Storb R, Mielcarek M. PMID: 29296873.
      View in: PubMed   Mentions:    Fields:    
    35. Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed? Leukemia. 2017 11; 31(11):2536-2537. Zhou Y, Wood BL, Walter RB, Becker PS, Percival ME, Bar M, Shaw C, Gardner K, Hendrie P, Abkowitz J, Appelbaum FR, Estey E. PMID: 28819284.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    36. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy. Br J Haematol. 2017 09; 178(6):906-913. Fenaux P, Muus P, Kantarjian H, Lyons RM, Larson RA, Sekeres MA, Becker PS, Orejudos A, Franklin J. PMID: 28616874.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    37. Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study. Leukemia. 2017 12; 31(12):2560-2567. Halpern AB, Othus M, Huebner EM, Buckley SA, Pogosova-Agadjanyan EL, Orlowski KF, Scott BL, Becker PS, Hendrie PC, Chen TL, Percival MM, Estey EH, Stirewalt DL, Walter RB. PMID: 28555084.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    38. Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin. Acta Haematol. 2017; 137(3):123-131. Holmberg LA, Becker PS, Bensinger W. PMID: 28355602.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Characterization of the novel HLA-B*49:39 allele identified in a German leukaemia patient. HLA. 2017 07; 90(1):43-45. Becker PSA, Lindner S, Kim-Wanner SZ, Bug G, Seidl C. PMID: 28371391.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    40. Flow cytometric demonstration of decrease in bone marrow leukemic blasts after 'Day 14' without further therapy in acute myeloid leukemia. Leuk Lymphoma. 2017 11; 58(11):2717-2719. Chen X, Othus M, Wood BL, Walter RB, Percival MM, Becker PS, Hendrie PC, Appelbaum FR, Estey EH. PMID: 28351184.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    41. Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm. Am J Hematol. 2017 May; 92(5):E75-E77. Ulrickson ML, Puri A, Lindstrom S, Cassaday RD, De Padova N, Becker PS. PMID: 28224664.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    42. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia. Curr Gene Ther. 2017; 16(5):338-348. Adair JE, Sevilla J, Heredia CD, Becker PS, Kiem HP, Bueren J. PMID: 28103787.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    43. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation. Amyloid. 2016 Dec; 23(4):254-259. Cowan AJ, Klippel ZK, Stevenson PA, Hyun TS, Tuazon S, Becker PS, Green DJ, Holmberg LA, Coffey DG, Gopal AK, Libby EN. PMID: 27879147.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. The novel HLA-C*15:103 is characterised by an amino acid substitution in the alpha 2 domain. HLA. 2016 11; 88(5):267-268. Becker PS, Paranikulangara P, Rettinger E, Bader P, Seidl C. PMID: 27647648.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    45. A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017 Jan; 52(1):59-65. Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S. PMID: 27427921.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    46. Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial. Lancet Haematol. 2016 Jul; 3(7):e330-9. Delaney C, Milano F, Cicconi L, Othus M, Becker PS, Sandhu V, Nicoud I, Dahlberg A, Bernstein ID, Appelbaum FR, Estey EH. PMID: 27374466.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    47. A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma. Blood Cancer J. 2016 05 13; 6:e422. Becker PS, Gooley TA, Green DJ, Burwick N, Kim TY, Kojouri K, Inoue Y, Moore DJ, Nelli E, Dennie T, Bensinger WI. PMID: 27176798.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    48. The Role of Biosimilars. J Natl Compr Canc Netw. 2016 05; 14(5 Suppl):626-9. Zelenetz AD, Becker PS. PMID: 27226500.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer. J Natl Compr Canc Netw. 2016 01; 14(1):8-17. Blau CA, Ramirez AB, Blau S, Pritchard CC, Dorschner MO, Schmechel SC, Martins TJ, Mahen EM, Burton KA, Komashko VM, Radenbaugh AJ, Dougherty K, Thomas A, Miller CP, Annis J, Fromm JR, Song C, Chang E, Howard K, Austin S, Schmidt RA, Linenberger ML, Becker PS, Senecal FM, Mecham BH, Lee SI, Madan A, Ronen R, Dutkowski J, Heimfeld S, Wood BL, Stilwell JL, Kaldjian EP, Haussler D, Zhu J. PMID: 26733551.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    50. Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy? Leuk Lymphoma. 2016 May; 57(5):1205-7. Araki D, Othus M, Walter RB, Becker PS, Sandhu V, Estey EH. PMID: 26694896.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS. Br J Haematol. 2016 Jan; 172(2):238-45. Mawad R, Becker PS, Hendrie P, Scott B, Wood BL, Dean C, Sandhu V, Deeg HJ, Walter R, Wang L, Myint H, Singer JW, Estey E, Pagel JM. PMID: 26568032.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    52. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis. JAMA Oncol. 2015 Nov; 1(8):1120-7. Vaughn JE, Othus M, Powell MA, Gardner KM, Rizzuto DL, Hendrie PC, Becker PS, Pottinger PS, Estey EH, Walter RB. PMID: 26355382.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    53. A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT. Bone Marrow Transplant. 2016 Jan; 51(1):67-71. Bensinger WI, Becker PS, Gooley TA, Chauncey TR, Maloney DG, Gopal AK, Green DJ, Press OW, Lill M, Ifthikharuddin JJ, Vescio R, Holmberg LA, Phillips GL. PMID: 26367217.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    54. Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission. Leuk Lymphoma. 2016; 57(3):572-6. Shadman M, Gopal AK, Kammerer B, Becker PS, Maloney DG, Pender B, Shustov AR, Press OW, Pagel JM. PMID: 26133724.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm? JAMA Oncol. 2015 Aug; 1(5):651-2. Scott BL, Becker PS. PMID: 26181358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients. Am J Clin Pathol. 2015 Aug; 144(2):263-70. Fang M, Becker PS, Linenberger M, Eaton KD, Appelbaum FR, Dreyer Z, Airewele G, Redell M, Lopez-Terrada D, Patel A, Rabin KR, Lu X. PMID: 26185311.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid. Br J Haematol. 2016 Jan; 172(1):134-6. Loeb KR, Cherian S, Becker PS, Walter RB, Pagel JM, Abkowitz JL, Appelbaum FR, Wood BL, Estey EH. PMID: 26010105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    58. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration. Blood Cancer J. 2015 Apr 10; 5:e302. Huang JC, Basu SK, Zhao X, Chien S, Fang M, Oehler VG, Appelbaum FR, Becker PS. PMID: 25860293.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    59. A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age. Br J Haematol. 2015 Aug; 170(3):349-55. Buckley SA, Mawad R, Gooley TA, Becker PS, Sandhu V, Hendrie P, Scott BL, Wood BL, Walter RB, Smith K, Dean C, Estey EH, Pagel JM. PMID: 25854284.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    60. Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia. Haematologica. 2015 Jul; 100(7):e254-6. Araki D, Othus M, Walter RB, Sandhu V, Sandmaier BM, Becker PS, Appelbaum FR, Estey EH. PMID: 25795719.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia. J Clin Oncol. 2015 Apr 10; 33(11):1258-64. Chen X, Xie H, Wood BL, Walter RB, Pagel JM, Becker PS, Sandhu VK, Abkowitz JL, Appelbaum FR, Estey EH. PMID: 25732155.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    62. Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome. Am J Hematol. 2015 Jun; 90(6):483-6. Shadman M, Mawad R, Dean C, Chen TL, Shannon-Dorcy K, Sandhu V, Hendrie PC, Scott BL, Walter RB, Becker PS, Pagel JM, Estey EH. PMID: 25689471.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    63. Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy. Leukemia. 2015 Aug; 29(8):1779-80. Chen X, Newell LF, Xie H, Walter RB, Pagel JM, Sandhu VK, Becker PS, Hendrie PC, Abkowitz JL, Appelbaum FR, Estey EH. PMID: 25650090.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    64. G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm. Am J Hematol. 2015 Apr; 90(4):295-300. Becker PS, Medeiros BC, Stein AS, Othus M, Appelbaum FR, Forman SJ, Scott BL, Hendrie PC, Gardner KM, Pagel JM, Walter RB, Parks C, Wood BL, Abkowitz JL, Estey EH. PMID: 25545153.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    65. Sparse expression bases in cancer reveal tumor drivers. Nucleic Acids Res. 2015 Feb 18; 43(3):1332-44. Logsdon BA, Gentles AJ, Miller CP, Blau CA, Becker PS, Lee SI. PMID: 25583238.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    66. Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia. Haematologica. 2015 Mar; 100(3):e97-8. Tong WG, Sandhu VK, Wood BL, Hendrie PC, Becker PS, Pagel JM, Walter RB, Estey EH. PMID: 25527567.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    67. Panobinostat: a review of trial results and future prospects in multiple myeloma. Expert Rev Hematol. 2015 Feb; 8(1):9-18. Libby EN, Becker PS, Burwick N, Green DJ, Holmberg L, Bensinger WI. PMID: 25410127.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    68. Optimizing stem cell mobilization: lessons learned. J Natl Compr Canc Netw. 2014 Oct; 12(10):1443-9. Becker PS. PMID: 25313183.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    69. Value of routine 'day 14' marrow exam in newly diagnosed AML. Leukemia. 2015 Jan; 29(1):247-9. Yezefski T, Xie H, Walter R, Pagel J, Becker PS, Hendrie P, Sandhu V, Shannon-Dorcy K, Abkowitz J, Appelbaum FR, Estey E. PMID: 25204570.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Management of Acute Myeloid Leukemia in the Intensive Care Setting. J Intensive Care Med. 2015 Oct; 30(7):375-84. Cowan AJ, Altemeier WA, Johnston C, Gernsheimer T, Becker PS. PMID: 24756309.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014 Aug; 20(8):1183-9. Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC. PMID: 24769014.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    72. Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design. Br J Haematol. 2014 Aug; 166(3):375-81. Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL, Deeg HJ, Becker PS, Hendrie PC, Walter RB, Ostronoff F, Appelbaum FR, Estey EH. PMID: 24749757.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    73. A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myeloma. Bone Marrow Transplant. 2014 Apr; 49(4):492-5. Bensinger WI, Green DJ, Burwick N, Becker PS. PMID: 24419523.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    74. Patient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma. Cancer Treat Commun. 2014; 2(2-3):34-47. Tariman JD, Doorenbos A, Schepp KG, Becker PS, Berry DL. PMID: 25553273.
      View in: PubMed   Mentions:
    75. Myeloid growth factors. J Natl Compr Canc Netw. 2013 Oct 01; 11(10):1266-90. Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Steensma DP, Talbott M, Vadhan-Raj S, Westervelt P, Westmoreland M, Dwyer M, Ho M. PMID: 24142827.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    76. Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission. J Clin Oncol. 2013 Nov 01; 31(31):3883-8. Mawad R, Gooley TA, Sandhu V, Lionberger J, Scott B, Sandmaier BM, O'Donnell P, Becker PS, Petersdorf S, Dorcy KS, Hendrie P, Sorror ML, Walter RB, Deeg HJ, Appelbaum FR, Estey EH, Pagel JM. PMID: 24062388.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia. Blood. 2013 Jul 11; 122(2):293-4. Veatch JR, Sandhu V, Becker PS, Pagel JM, Appelbaum FR, Estey E. PMID: 23847187.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia. Br J Haematol. 2013 Oct; 163(1):130-2. Ostronoff F, Othus M, Kantarjian HM, Meshinchi S, Ravandi F, Hendrie PC, Faderl S, Becker PS, Cortes JE, Pagel JM, Petersdorf SH, Godwin JE, Willman CL, Pierce SA, List AF, Sandhu RK, Walter RB, Stirewalt DL, Appelbaum FR, Estey EH. PMID: 23829510.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    79. Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML). Leuk Res Rep. 2013; 2(1):26-8. Chow V, Dorcy KS, Sandhu R, Gardner K, Becker P, Pagel J, Hendrie P, Abkowitz J, Appelbaum F, Estey E. PMID: 24371771.
      View in: PubMed   Mentions:
    80. Immune defects in a mouse model of Fanconi anaemia. Br J Haematol. 2012 Oct; 159(2):246-50. Holmgren SC, Goren EM, Wood BL, Becker PS, Taylor JA. PMID: 22897682.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    81. A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. Br J Haematol. 2012 Oct; 159(1):58-66. Bensinger W, Maziarz RT, Jagannath S, Spencer A, Durrant S, Becker PS, Ewald B, Bilic S, Rediske J, Baeck J, Stadtmauer EA. PMID: 22861192.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    82. The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia. Leukemia. 2013 Mar; 27(3):728-31. Roshal M, Chien S, Othus M, Wood BL, Fang M, Appelbaum FR, Estey EH, Papayannopoulou T, Becker PS. PMID: 22926686.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    83. Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia. Haematologica. 2013 Jan; 98(1):114-8. Becker PS, Kantarjian HM, Appelbaum FR, Storer B, Pierce S, Shan J, Faderl S, Estey EH. PMID: 22801963.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    84. Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities. J Mol Med (Berl). 2012 Nov; 90(11):1283-94. Adair JE, Zhao X, Chien S, Fang M, Wohlfahrt ME, Trobridge GD, Taylor JA, Beard BC, Kiem HP, Becker PS. PMID: 22660274.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    85. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2012 May; 10(5):628-53. Rodgers GM, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, Matulonis UA, Millenson MM, Reinke D, Rosenthal J, Schwartz RN, Soff G, Stein RS, Vlahovic G, Weir AB. PMID: 22570293.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    86. Evaluating surface erythropoietin receptor in multiple myeloma. Leukemia. 2012 Aug; 26(8):1883-6. Miller CP, Rattray K, Zhang Y, Wood BL, Burwick N, Chien S, Bensinger WI, Blau CA, Becker PS. PMID: 22377897.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther. 2012 Feb; 23(2):141-4. Tolar J, Becker PS, Clapp DW, Hanenberg H, de Heredia CD, Kiem HP, Navarro S, Qasba P, Rio P, Schmidt M, Sevilla J, Verhoeyen E, Thrasher AJ, Bueren J. PMID: 22248350.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    88. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment. ScientificWorldJournal. 2012; 2012:856467. Becker PS. PMID: 22346731.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    89. Hematopoietic stem cell mobilization for gene therapy of adult patients with severe ß-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects. Mol Ther. 2012 01; 20(1):230-8. Yannaki E, Papayannopoulou T, Jonlin E, Zervou F, Karponi G, Xagorari A, Becker P, Psatha N, Batsis I, Kaloyannidis P, Tahynopoulou V, Constantinou V, Bouinta A, Kotta K, Athanassiadou A, Anagnostopoulos A, Fassas A, Stamatoyannopoulos G. PMID: 21952171.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    90. Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia. Br J Haematol. 2011 Oct; 155(2):182-9. Becker PS, Kantarjian HM, Appelbaum FR, Petersdorf SH, Storer B, Pierce S, Shan J, Hendrie PC, Pagel JM, Shustov AR, Stirewalt DL, Faderl S, Harrington E, Estey EH. PMID: 21848522.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    91. Multiple myeloma: diagnosis and orthopaedic implications. J Am Acad Orthop Surg. 2011 Jul; 19(7):410-9. Scharschmidt TJ, Lindsey JD, Becker PS, Conrad EU. PMID: 21724920.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine. Leuk Res. 2011 Sep; 35(9):e164-6. Knoebel RW, McQuary A, Becker P, Hendrie P, Petersdorf S, Appelbaum FR, Estey E. PMID: 21684006.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting. Mol Ther. 2011 Jul; 19(7):1193-8. Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp DW, Dalgleish R, Galy A, Gaspar HB, Hanenberg H, Von Kalle C, Kiem HP, Lindeman D, Naldini L, Navarro S, Renella R, Rio P, Sevilla J, Schmidt M, Verhoeyen E, Wagner JE, Williams DA, Thrasher AJ. PMID: 21540837.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    94. Genetic predisposition for chemotherapy-induced neuropathy in multiple myeloma. J Clin Oncol. 2011 Mar 01; 29(7):783-6. Becker PS. PMID: 21245424.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. Cancer. 2011 Mar 01; 117(5):992-1000. Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D. PMID: 20945323.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    96. Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. Gene Ther. 2010 Oct; 17(10):1244-52. Becker PS, Taylor JA, Trobridge GD, Zhao X, Beard BC, Chien S, Adair J, Kohn DB, Wagner JE, Shimamura A, Kiem HP. PMID: 20485382.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    97. Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study. Br J Haematol. 2010 Jun; 149(5):706-10. Scott BL, Ramakrishnan A, Fosdal M, Storer B, Becker P, Petersdorf S, Deeg HJ. PMID: 20331464.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    98. Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept. Br J Haematol. 2010 Mar; 148(6):944-7. Scott BL, Ramakrishnan A, Storer B, Becker PS, Petersdorf S, Estey EH, Deeg HJ. PMID: 20064151.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    99. Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. J Clin Oncol. 2010 Jan 20; 28(3):437-44. Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP. PMID: 20008626.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    100. Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma. Br J Haematol. 2010 Feb; 148(4):562-8. Bensinger WI, Jagannath S, Vescio R, Camacho E, Wolf J, Irwin D, Capo G, McKinley M, Potts P, Vesole DH, Mazumder A, Crowley J, Becker P, Hilger J, Durie BG. PMID: 19919652.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    101. Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer. Semin Dial. 2009 Jan-Feb; 22(1):1-4. Bennett CL, Becker PS, Kraut EH, Samaras AT, West DP. PMID: 19175532.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia. Blood. 2009 Jan 22; 113(4):866-74. Becker PS, Kopecky KJ, Wilks AN, Chien S, Harlan JM, Willman CL, Petersdorf SH, Stirewalt DL, Papayannopoulou T, Appelbaum FR. PMID: 18927435.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    103. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2008 Jul; 6(6):536-64. Rodgers GM, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R. PMID: 18597709.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    104. Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment. Exp Hematol. 2006 May; 34(5):680-7. Gold J, Valinski HM, Hanks AN, Ballen KK, Hsieh CC, Becker PS. PMID: 16647574.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. The current status of gene therapy in autologous transplantation. Acta Haematol. 2005; 114(4):188-97. Becker PS. PMID: 16269858.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    106. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res. 2005 Jan 01; 65(1):358-63. Baik I, Devito WJ, Ballen K, Becker PS, Okulicz W, Liu Q, Delpapa E, Lagiou P, Sturgeon S, Trichopoulos D, Quesenberry PJ, Hsieh CC. PMID: 15665314.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    107. Growth factor priming in therapy of acute myelogenous leukemia. Curr Hematol Rep. 2004 Nov; 3(6):413-8. Becker PS. PMID: 15496274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    108. Autologous stem-cell transplantation can be performed safely without the use of blood-product support. J Clin Oncol. 2004 Oct 15; 22(20):4087-94. Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA. PMID: 15353543.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    109. Stem cells and prenatal origin of breast cancer. Cancer Causes Control. 2004 Jun; 15(5):517-30. Baik I, Becker PS, DeVito WJ, Lagiou P, Ballen K, Quesenberry PJ, Hsieh CC. PMID: 15286472.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    110. A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells. Stem Cells. 2004; 22(6):1030-8. Nowakowski GS, Dooner MS, Valinski HM, Mihaliak AM, Quesenberry PJ, Becker PS. PMID: 15536193.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    111. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med. 2003 Jun 02; 197(11):1563-72. Lambert JF, Liu M, Colvin GA, Dooner M, McAuliffe CI, Becker PS, Forget BG, Weissman SM, Quesenberry PJ. PMID: 12782718.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    112. High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma. Bone Marrow Transplant. 2003 Mar; 31(6):441-6. Rossi HA, Becker PS, Emmons RV, Westervelt P, Levy W, Liu Q, Clark Y, Ballen K. PMID: 12665838.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    113. Homing of purified murine lymphohematopoietic stem cells: a cytokine-induced defect. J Hematother Stem Cell Res. 2002 Dec; 11(6):913-22. Cerny J, Dooner M, McAuliffe C, Habibian H, Stencil K, Berrios V, Reilly J, Carlson J, Cerny AM, d'Hondt L, Benoit B, Lambert JF, Colvin G, Nilsson S, Becker P, Quesenberry P. PMID: 12590706.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    114. Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood. 2002 Jul 15; 100(2):442-50. Ballen KK, Becker PS, Emmons RV, Fitzgerald TJ, Hsieh CC, Liu Q, Heyes C, Clark Y, Levy W, Lambert JF, Chiafari F, Szymanski I, Rososhansky S, Popovsky MA, Stewart FM, Quesenberry PJ. PMID: 12091334.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    115. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia. 2002 Mar; 16(3):310-5. Rossi HA, O'Donnell J, Sarcinelli F, Stewart FM, Quesenberry PJ, Becker PS. PMID: 11896533.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    116. The new stem cell biology. Trans Am Clin Climatol Assoc. 2002; 113:182-206; discussion 206-7. Quesenberry PJ, Colvin GA, Lambert JF, Frimberger AE, Dooner MS, Mcauliffe CI, Miller C, Becker P, Badiavas E, Falanga VJ, Elfenbein G, Lum LG. PMID: 12053709.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    117. Hematopoietic stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges. J Cell Biochem Suppl. 2002; 38:55-64. Becker PS. PMID: 12046850.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    118. Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support. Bone Marrow Transplant. 2001 Dec; 28(11):1061-6. Ballen KK, Hesketh AM, Heyes C, Becker PS, Emmons RV, Fogarty K, LaPointe J, Liu Q, Hsieh CC, Hesketh PJ. PMID: 11781617.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    119. The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Exp Hematol. 2001 Nov; 29(11):1326-35. Berrios VM, Dooner GJ, Nowakowski G, Frimberger A, Valinski H, Quesenberry PJ, Becker PS. PMID: 11698129.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    120. Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic--severe combined immunodeficient assay. Br J Haematol. 2001 Jul; 114(1):211-8. Ballen KK, Valinski H, Greiner D, Shultz LD, Becker PS, Hsieh CC, Stewart FM, Quesenberry PJ. PMID: 11472370.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    121. Manipulation of the stem cell as a target for hematologic malignancies. Semin Oncol. 2000 Oct; 27(5):512-23. Ballen KK, Becker PS, Stewart FM, Quesenberry PJ. PMID: 11049019.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    122. Successful autologous bone marrow transplant without the use of blood product support. Bone Marrow Transplant. 2000 Jul; 26(2):227-9. Ballen KK, Ford PA, Waitkus H, Emmons RV, Levy W, Doyle P, Stewart FM, Quesenberry PJ, Becker PS. PMID: 10918437.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro. Exp Hematol. 2000 Jul; 28(7):765-74. Dooner GJ, Barker JE, Gallagher PG, Debatis ME, Brown AH, Forget BG, Becker PS. PMID: 10907638.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    124. Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice. Br J Haematol. 2000 Mar; 108(3):629-40. Ballen K, Becker PS, Greiner D, Valinski H, Shearin D, Berrios V, Dooner G, Hsieh CC, Wuu J, Shultz L, Cerny J, Leif J, Stewart FM, Quesenberry P. PMID: 10759723.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    125. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp Hematol. 1999 Mar; 27(3):533-41. Becker PS, Nilsson SK, Li Z, Berrios VM, Dooner MS, Cooper CL, Hsieh CC, Quesenberry PJ. PMID: 10089917.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    126. Gene transfer in the nonmyeloablated host. Prog Exp Tumor Res. 1999; 36:172-8. Quesenberry PJ, Becker PS. PMID: 10386073.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    127. Stem cell homing: rolling, crawling, and nesting. Proc Natl Acad Sci U S A. 1998 Dec 22; 95(26):15155-7. Quesenberry PJ, Becker PS. PMID: 9860935.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    128. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem. 1998 Mar; 46(3):371-7. Nilsson SK, Debatis ME, Dooner MS, Madri JA, Quesenberry PJ, Becker PS. PMID: 9487119.
      View in: PubMed   Mentions: 53     Fields:    Translation:Animals
    129. Giant platelets with abnormal surface glycoproteins: a new familial disorder associated with mitral valve insufficiency. J Pediatr Hematol Oncol. 1998 Jan-Feb; 20(1):69-73. Becker PS, Clavell LA, Beardsley DS. PMID: 9482416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    130. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997 Apr; 3(1):45-9. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, Stewart FM, Heard SO. PMID: 9209740.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    131. Laminin promotes differentiation of NB4 promyelocytic leukemia cells with all-trans retinoic acid. Blood. 1996 Jul 01; 88(1):261-7. Becker PS, Li Z, Potselueva T, Madri JA, Newburger PE, Berliner N. PMID: 8704182.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    132. Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J Clin Invest. 1993 Aug; 92(2):612-6. Becker PS, Tse WT, Lux SE, Forget BG. PMID: 8102379.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    133. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol. 1992 Apr; 31(4):349-60. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE. PMID: 1586135.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    Pamela's Networks
    Concepts (500)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (4)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑